nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromocriptine—ABCB1—kidney cancer	0.174	1	CbGaD
Bromocriptine—HTR2B—Sorafenib—kidney cancer	0.0655	0.131	CbGbCtD
Bromocriptine—ABCB1—Temsirolimus—kidney cancer	0.0445	0.0887	CbGbCtD
Bromocriptine—HTR2C—Sorafenib—kidney cancer	0.0426	0.085	CbGbCtD
Bromocriptine—CYP3A4—Everolimus—kidney cancer	0.0395	0.0787	CbGbCtD
Bromocriptine—CYP1A2—Pazopanib—kidney cancer	0.0267	0.0533	CbGbCtD
Bromocriptine—CYP3A4—Temsirolimus—kidney cancer	0.0266	0.0531	CbGbCtD
Bromocriptine—ABCB1—Pazopanib—kidney cancer	0.0234	0.0466	CbGbCtD
Bromocriptine—ABCB1—Dactinomycin—kidney cancer	0.0214	0.0426	CbGbCtD
Bromocriptine—CYP1A2—Erlotinib—kidney cancer	0.0191	0.038	CbGbCtD
Bromocriptine—ABCB1—Gemcitabine—kidney cancer	0.0169	0.0337	CbGbCtD
Bromocriptine—ABCB1—Erlotinib—kidney cancer	0.0167	0.0332	CbGbCtD
Bromocriptine—CYP1A2—Sorafenib—kidney cancer	0.0155	0.0309	CbGbCtD
Bromocriptine—ABCB1—Paclitaxel—kidney cancer	0.0153	0.0304	CbGbCtD
Bromocriptine—CYP3A4—Pazopanib—kidney cancer	0.014	0.0279	CbGbCtD
Bromocriptine—ABCB1—Sorafenib—kidney cancer	0.0136	0.027	CbGbCtD
Bromocriptine—ABCB1—Vinblastine—kidney cancer	0.0134	0.0267	CbGbCtD
Bromocriptine—ABCB1—Vincristine—kidney cancer	0.0132	0.0262	CbGbCtD
Bromocriptine—ABCB1—Sunitinib—kidney cancer	0.011	0.0219	CbGbCtD
Bromocriptine—CYP3A4—Erlotinib—kidney cancer	0.00999	0.0199	CbGbCtD
Bromocriptine—CYP3A4—Paclitaxel—kidney cancer	0.00914	0.0182	CbGbCtD
Bromocriptine—ABCB1—Doxorubicin—kidney cancer	0.00822	0.0164	CbGbCtD
Bromocriptine—CYP3A4—Sorafenib—kidney cancer	0.00812	0.0162	CbGbCtD
Bromocriptine—CYP3A4—Vinblastine—kidney cancer	0.00802	0.016	CbGbCtD
Bromocriptine—CYP3A4—Vincristine—kidney cancer	0.00788	0.0157	CbGbCtD
Bromocriptine—CYP3A4—Sunitinib—kidney cancer	0.00658	0.0131	CbGbCtD
Bromocriptine—CYP3A4—Doxorubicin—kidney cancer	0.00493	0.00983	CbGbCtD
Bromocriptine—CYP1A2—urine—kidney cancer	0.000983	0.102	CbGeAlD
Bromocriptine—HTR2A—urine—kidney cancer	0.000768	0.0795	CbGeAlD
Bromocriptine—CYP3A4—urine—kidney cancer	0.000711	0.0736	CbGeAlD
Bromocriptine—ADRA1B—renal system—kidney cancer	0.000517	0.0536	CbGeAlD
Bromocriptine—Dihydroergotamine—ABCB1—kidney cancer	0.000506	0.411	CrCbGaD
Bromocriptine—ADRA1B—kidney—kidney cancer	0.0005	0.0518	CbGeAlD
Bromocriptine—Ergonovine—ABCB1—kidney cancer	0.000463	0.376	CrCbGaD
Bromocriptine—HTR1D—kidney—kidney cancer	0.000366	0.0379	CbGeAlD
Bromocriptine—HTR2B—cortex of kidney—kidney cancer	0.000331	0.0343	CbGeAlD
Bromocriptine—ADRB1—cardiac atrium—kidney cancer	0.000329	0.0341	CbGeAlD
Bromocriptine—HTR1A—renal system—kidney cancer	0.000315	0.0326	CbGeAlD
Bromocriptine—ADRA2C—nephron tubule—kidney cancer	0.000305	0.0315	CbGeAlD
Bromocriptine—HTR7—renal system—kidney cancer	0.000301	0.0312	CbGeAlD
Bromocriptine—HTR7—kidney—kidney cancer	0.000291	0.0302	CbGeAlD
Bromocriptine—ADRA1A—renal system—kidney cancer	0.000291	0.0301	CbGeAlD
Bromocriptine—ADRA2C—renal system—kidney cancer	0.000277	0.0287	CbGeAlD
Bromocriptine—HTR7—gonad—kidney cancer	0.00027	0.028	CbGeAlD
Bromocriptine—ADRA2C—kidney—kidney cancer	0.000268	0.0277	CbGeAlD
Bromocriptine—ADRA2C—cortex of kidney—kidney cancer	0.000261	0.027	CbGeAlD
Bromocriptine—Ergotamine—ABCB1—kidney cancer	0.000261	0.212	CrCbGaD
Bromocriptine—ADRA2C—cardiac atrium—kidney cancer	0.000248	0.0257	CbGeAlD
Bromocriptine—CYP1A2—renal system—kidney cancer	0.00024	0.0249	CbGeAlD
Bromocriptine—Muscle spasms—Paclitaxel—kidney cancer	0.000212	0.000827	CcSEcCtD
Bromocriptine—Body temperature increased—Sunitinib—kidney cancer	0.000211	0.000826	CcSEcCtD
Bromocriptine—Abdominal pain—Sunitinib—kidney cancer	0.000211	0.000826	CcSEcCtD
Bromocriptine—Diarrhoea—Erlotinib—kidney cancer	0.000211	0.000826	CcSEcCtD
Bromocriptine—Hypotension—Vincristine—kidney cancer	0.000211	0.000826	CcSEcCtD
Bromocriptine—Bradycardia—Capecitabine—kidney cancer	0.000211	0.000826	CcSEcCtD
Bromocriptine—Nervous system disorder—Gemcitabine—kidney cancer	0.00021	0.000823	CcSEcCtD
Bromocriptine—Feeling abnormal—Dactinomycin—kidney cancer	0.000209	0.000815	CcSEcCtD
Bromocriptine—Skin disorder—Gemcitabine—kidney cancer	0.000208	0.000815	CcSEcCtD
Bromocriptine—ADRA2A—cortex of kidney—kidney cancer	0.000208	0.0215	CbGeAlD
Bromocriptine—Rhinitis—Capecitabine—kidney cancer	0.000208	0.000813	CcSEcCtD
Bromocriptine—Vision blurred—Paclitaxel—kidney cancer	0.000207	0.000811	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000207	0.000809	CcSEcCtD
Bromocriptine—Hypoaesthesia—Capecitabine—kidney cancer	0.000206	0.000807	CcSEcCtD
Bromocriptine—Insomnia—Vincristine—kidney cancer	0.000205	0.0008	CcSEcCtD
Bromocriptine—Anorexia—Gemcitabine—kidney cancer	0.000205	0.0008	CcSEcCtD
Bromocriptine—Oedema peripheral—Capecitabine—kidney cancer	0.000204	0.000799	CcSEcCtD
Bromocriptine—Vomiting—Vinblastine—kidney cancer	0.000204	0.000799	CcSEcCtD
Bromocriptine—Dizziness—Erlotinib—kidney cancer	0.000204	0.000799	CcSEcCtD
Bromocriptine—Connective tissue disorder—Capecitabine—kidney cancer	0.000204	0.000797	CcSEcCtD
Bromocriptine—Vomiting—Everolimus—kidney cancer	0.000204	0.000796	CcSEcCtD
Bromocriptine—Paraesthesia—Vincristine—kidney cancer	0.000203	0.000794	CcSEcCtD
Bromocriptine—Agitation—Paclitaxel—kidney cancer	0.000202	0.000791	CcSEcCtD
Bromocriptine—Rash—Everolimus—kidney cancer	0.000202	0.000789	CcSEcCtD
Bromocriptine—Dermatitis—Everolimus—kidney cancer	0.000202	0.000788	CcSEcCtD
Bromocriptine—Headache—Vinblastine—kidney cancer	0.000201	0.000787	CcSEcCtD
Bromocriptine—Headache—Everolimus—kidney cancer	0.000201	0.000784	CcSEcCtD
Bromocriptine—Hypotension—Gemcitabine—kidney cancer	0.0002	0.000784	CcSEcCtD
Bromocriptine—Body temperature increased—Dactinomycin—kidney cancer	0.0002	0.000782	CcSEcCtD
Bromocriptine—Abdominal pain—Dactinomycin—kidney cancer	0.0002	0.000782	CcSEcCtD
Bromocriptine—Visual impairment—Capecitabine—kidney cancer	0.0002	0.000782	CcSEcCtD
Bromocriptine—Asthenia—Sorafenib—kidney cancer	0.000199	0.000779	CcSEcCtD
Bromocriptine—ADRA2A—gonad—kidney cancer	0.000198	0.0205	CbGeAlD
Bromocriptine—Hypoglycaemia—Doxorubicin—kidney cancer	0.000198	0.000774	CcSEcCtD
Bromocriptine—ADRA2A—cardiac atrium—kidney cancer	0.000198	0.0205	CbGeAlD
Bromocriptine—Vertigo—Paclitaxel—kidney cancer	0.000198	0.000773	CcSEcCtD
Bromocriptine—Syncope—Paclitaxel—kidney cancer	0.000197	0.000772	CcSEcCtD
Bromocriptine—Lethargy—Doxorubicin—kidney cancer	0.000197	0.000771	CcSEcCtD
Bromocriptine—Cerebrovascular accident—Doxorubicin—kidney cancer	0.000197	0.000771	CcSEcCtD
Bromocriptine—Decreased appetite—Vincristine—kidney cancer	0.000197	0.000769	CcSEcCtD
Bromocriptine—Vomiting—Erlotinib—kidney cancer	0.000196	0.000768	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Vincristine—kidney cancer	0.000195	0.000763	CcSEcCtD
Bromocriptine—Fatigue—Vincristine—kidney cancer	0.000195	0.000762	CcSEcCtD
Bromocriptine—Rash—Erlotinib—kidney cancer	0.000195	0.000761	CcSEcCtD
Bromocriptine—Dermatitis—Erlotinib—kidney cancer	0.000195	0.000761	CcSEcCtD
Bromocriptine—Insomnia—Gemcitabine—kidney cancer	0.000194	0.000759	CcSEcCtD
Bromocriptine—Eye disorder—Capecitabine—kidney cancer	0.000194	0.000758	CcSEcCtD
Bromocriptine—Headache—Erlotinib—kidney cancer	0.000193	0.000756	CcSEcCtD
Bromocriptine—Tinnitus—Capecitabine—kidney cancer	0.000193	0.000756	CcSEcCtD
Bromocriptine—Loss of consciousness—Paclitaxel—kidney cancer	0.000193	0.000756	CcSEcCtD
Bromocriptine—Constipation—Vincristine—kidney cancer	0.000193	0.000756	CcSEcCtD
Bromocriptine—Gastrointestinal haemorrhage—Doxorubicin—kidney cancer	0.000193	0.000756	CcSEcCtD
Bromocriptine—Diplopia—Doxorubicin—kidney cancer	0.000193	0.000756	CcSEcCtD
Bromocriptine—Paraesthesia—Gemcitabine—kidney cancer	0.000193	0.000753	CcSEcCtD
Bromocriptine—Cardiac disorder—Capecitabine—kidney cancer	0.000193	0.000753	CcSEcCtD
Bromocriptine—Asthenia—Sunitinib—kidney cancer	0.000192	0.00075	CcSEcCtD
Bromocriptine—Dyspnoea—Gemcitabine—kidney cancer	0.000191	0.000748	CcSEcCtD
Bromocriptine—Nausea—Vinblastine—kidney cancer	0.000191	0.000746	CcSEcCtD
Bromocriptine—Somnolence—Gemcitabine—kidney cancer	0.000191	0.000746	CcSEcCtD
Bromocriptine—Convulsion—Paclitaxel—kidney cancer	0.000191	0.000746	CcSEcCtD
Bromocriptine—Nausea—Everolimus—kidney cancer	0.00019	0.000743	CcSEcCtD
Bromocriptine—Diarrhoea—Sorafenib—kidney cancer	0.00019	0.000743	CcSEcCtD
Bromocriptine—Hypertension—Paclitaxel—kidney cancer	0.00019	0.000743	CcSEcCtD
Bromocriptine—Angiopathy—Capecitabine—kidney cancer	0.000188	0.000736	CcSEcCtD
Bromocriptine—HTR2A—renal system—kidney cancer	0.000188	0.0195	CbGeAlD
Bromocriptine—Mediastinal disorder—Capecitabine—kidney cancer	0.000187	0.000731	CcSEcCtD
Bromocriptine—Anxiety—Paclitaxel—kidney cancer	0.000187	0.00073	CcSEcCtD
Bromocriptine—Decreased appetite—Gemcitabine—kidney cancer	0.000186	0.000729	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000186	0.000728	CcSEcCtD
Bromocriptine—Arrhythmia—Capecitabine—kidney cancer	0.000185	0.000725	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000185	0.000724	CcSEcCtD
Bromocriptine—Fatigue—Gemcitabine—kidney cancer	0.000185	0.000723	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Vincristine—kidney cancer	0.000185	0.000723	CcSEcCtD
Bromocriptine—Dizziness—Sorafenib—kidney cancer	0.000184	0.000718	CcSEcCtD
Bromocriptine—Constipation—Gemcitabine—kidney cancer	0.000183	0.000717	CcSEcCtD
Bromocriptine—Nausea—Erlotinib—kidney cancer	0.000183	0.000717	CcSEcCtD
Bromocriptine—Alopecia—Capecitabine—kidney cancer	0.000183	0.000717	CcSEcCtD
Bromocriptine—Dry mouth—Paclitaxel—kidney cancer	0.000183	0.000716	CcSEcCtD
Bromocriptine—Diarrhoea—Sunitinib—kidney cancer	0.000183	0.000715	CcSEcCtD
Bromocriptine—Ataxia—Doxorubicin—kidney cancer	0.000182	0.000711	CcSEcCtD
Bromocriptine—Mental disorder—Capecitabine—kidney cancer	0.000182	0.000711	CcSEcCtD
Bromocriptine—HTR2A—kidney—kidney cancer	0.000182	0.0188	CbGeAlD
Bromocriptine—Asthenia—Dactinomycin—kidney cancer	0.000182	0.00071	CcSEcCtD
Bromocriptine—Confusional state—Paclitaxel—kidney cancer	0.000181	0.000708	CcSEcCtD
Bromocriptine—Oedema—Paclitaxel—kidney cancer	0.00018	0.000702	CcSEcCtD
Bromocriptine—Body temperature increased—Vincristine—kidney cancer	0.000179	0.000699	CcSEcCtD
Bromocriptine—Abdominal pain—Vincristine—kidney cancer	0.000179	0.000699	CcSEcCtD
Bromocriptine—Infection—Paclitaxel—kidney cancer	0.000178	0.000698	CcSEcCtD
Bromocriptine—Dysgeusia—Capecitabine—kidney cancer	0.000177	0.000691	CcSEcCtD
Bromocriptine—Dizziness—Sunitinib—kidney cancer	0.000177	0.000691	CcSEcCtD
Bromocriptine—Feeling abnormal—Gemcitabine—kidney cancer	0.000177	0.000691	CcSEcCtD
Bromocriptine—Shock—Paclitaxel—kidney cancer	0.000177	0.000691	CcSEcCtD
Bromocriptine—Vomiting—Sorafenib—kidney cancer	0.000177	0.000691	CcSEcCtD
Bromocriptine—Orthostatic hypotension—Doxorubicin—kidney cancer	0.000177	0.00069	CcSEcCtD
Bromocriptine—Abdominal pain upper—Doxorubicin—kidney cancer	0.000177	0.00069	CcSEcCtD
Bromocriptine—Nervous system disorder—Paclitaxel—kidney cancer	0.000176	0.000689	CcSEcCtD
Bromocriptine—Tachycardia—Paclitaxel—kidney cancer	0.000175	0.000685	CcSEcCtD
Bromocriptine—Rash—Sorafenib—kidney cancer	0.000175	0.000685	CcSEcCtD
Bromocriptine—Dermatitis—Sorafenib—kidney cancer	0.000175	0.000684	CcSEcCtD
Bromocriptine—Skin disorder—Paclitaxel—kidney cancer	0.000174	0.000682	CcSEcCtD
Bromocriptine—Headache—Sorafenib—kidney cancer	0.000174	0.000681	CcSEcCtD
Bromocriptine—CYP3A4—renal system—kidney cancer	0.000174	0.018	CbGeAlD
Bromocriptine—Muscle spasms—Capecitabine—kidney cancer	0.000174	0.000679	CcSEcCtD
Bromocriptine—Diarrhoea—Dactinomycin—kidney cancer	0.000173	0.000677	CcSEcCtD
Bromocriptine—Nasopharyngitis—Doxorubicin—kidney cancer	0.000173	0.000676	CcSEcCtD
Bromocriptine—Anorexia—Paclitaxel—kidney cancer	0.000171	0.000669	CcSEcCtD
Bromocriptine—Vision blurred—Capecitabine—kidney cancer	0.00017	0.000665	CcSEcCtD
Bromocriptine—Vomiting—Sunitinib—kidney cancer	0.00017	0.000665	CcSEcCtD
Bromocriptine—Body temperature increased—Gemcitabine—kidney cancer	0.00017	0.000663	CcSEcCtD
Bromocriptine—Rash—Sunitinib—kidney cancer	0.000169	0.000659	CcSEcCtD
Bromocriptine—HTR2A—gonad—kidney cancer	0.000169	0.0174	CbGeAlD
Bromocriptine—Dermatitis—Sunitinib—kidney cancer	0.000168	0.000658	CcSEcCtD
Bromocriptine—CYP3A4—kidney—kidney cancer	0.000168	0.0174	CbGeAlD
Bromocriptine—Hypotension—Paclitaxel—kidney cancer	0.000168	0.000656	CcSEcCtD
Bromocriptine—Headache—Sunitinib—kidney cancer	0.000168	0.000655	CcSEcCtD
Bromocriptine—Influenza—Doxorubicin—kidney cancer	0.000167	0.000653	CcSEcCtD
Bromocriptine—Dysphagia—Doxorubicin—kidney cancer	0.000167	0.000653	CcSEcCtD
Bromocriptine—Nausea—Sorafenib—kidney cancer	0.000165	0.000645	CcSEcCtD
Bromocriptine—Insomnia—Paclitaxel—kidney cancer	0.000162	0.000635	CcSEcCtD
Bromocriptine—Vertigo—Capecitabine—kidney cancer	0.000162	0.000634	CcSEcCtD
Bromocriptine—Asthenia—Vincristine—kidney cancer	0.000162	0.000634	CcSEcCtD
Bromocriptine—Syncope—Capecitabine—kidney cancer	0.000162	0.000633	CcSEcCtD
Bromocriptine—Paraesthesia—Paclitaxel—kidney cancer	0.000161	0.000631	CcSEcCtD
Bromocriptine—Vomiting—Dactinomycin—kidney cancer	0.000161	0.000629	CcSEcCtD
Bromocriptine—Dyspnoea—Paclitaxel—kidney cancer	0.00016	0.000626	CcSEcCtD
Bromocriptine—Somnolence—Paclitaxel—kidney cancer	0.00016	0.000624	CcSEcCtD
Bromocriptine—Rash—Dactinomycin—kidney cancer	0.00016	0.000624	CcSEcCtD
Bromocriptine—Nausea—Sunitinib—kidney cancer	0.000159	0.000621	CcSEcCtD
Bromocriptine—Loss of consciousness—Capecitabine—kidney cancer	0.000159	0.000621	CcSEcCtD
Bromocriptine—Dyspepsia—Paclitaxel—kidney cancer	0.000158	0.000618	CcSEcCtD
Bromocriptine—Decreased appetite—Paclitaxel—kidney cancer	0.000156	0.00061	CcSEcCtD
Bromocriptine—Hypertension—Capecitabine—kidney cancer	0.000156	0.00061	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000155	0.000606	CcSEcCtD
Bromocriptine—Fatigue—Paclitaxel—kidney cancer	0.000155	0.000605	CcSEcCtD
Bromocriptine—Diarrhoea—Vincristine—kidney cancer	0.000155	0.000605	CcSEcCtD
Bromocriptine—Pollakiuria—Doxorubicin—kidney cancer	0.000154	0.000603	CcSEcCtD
Bromocriptine—Asthenia—Gemcitabine—kidney cancer	0.000154	0.000602	CcSEcCtD
Bromocriptine—Constipation—Paclitaxel—kidney cancer	0.000154	0.000601	CcSEcCtD
Bromocriptine—Anxiety—Capecitabine—kidney cancer	0.000153	0.000599	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000153	0.000597	CcSEcCtD
Bromocriptine—Dry mouth—Capecitabine—kidney cancer	0.00015	0.000588	CcSEcCtD
Bromocriptine—Nausea—Dactinomycin—kidney cancer	0.00015	0.000588	CcSEcCtD
Bromocriptine—Dizziness—Vincristine—kidney cancer	0.00015	0.000585	CcSEcCtD
Bromocriptine—Drowsiness—Doxorubicin—kidney cancer	0.000149	0.000582	CcSEcCtD
Bromocriptine—Confusional state—Capecitabine—kidney cancer	0.000149	0.000581	CcSEcCtD
Bromocriptine—Feeling abnormal—Paclitaxel—kidney cancer	0.000148	0.000579	CcSEcCtD
Bromocriptine—Oedema—Capecitabine—kidney cancer	0.000147	0.000576	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000147	0.000574	CcSEcCtD
Bromocriptine—Diarrhoea—Gemcitabine—kidney cancer	0.000147	0.000574	CcSEcCtD
Bromocriptine—Infection—Capecitabine—kidney cancer	0.000146	0.000573	CcSEcCtD
Bromocriptine—Shock—Capecitabine—kidney cancer	0.000145	0.000567	CcSEcCtD
Bromocriptine—Nervous system disorder—Capecitabine—kidney cancer	0.000145	0.000565	CcSEcCtD
Bromocriptine—Tachycardia—Capecitabine—kidney cancer	0.000144	0.000562	CcSEcCtD
Bromocriptine—Vomiting—Vincristine—kidney cancer	0.000144	0.000562	CcSEcCtD
Bromocriptine—Skin disorder—Capecitabine—kidney cancer	0.000143	0.00056	CcSEcCtD
Bromocriptine—Urticaria—Paclitaxel—kidney cancer	0.000143	0.000558	CcSEcCtD
Bromocriptine—Rash—Vincristine—kidney cancer	0.000143	0.000557	CcSEcCtD
Bromocriptine—Dermatitis—Vincristine—kidney cancer	0.000142	0.000557	CcSEcCtD
Bromocriptine—Body temperature increased—Paclitaxel—kidney cancer	0.000142	0.000555	CcSEcCtD
Bromocriptine—Abdominal pain—Paclitaxel—kidney cancer	0.000142	0.000555	CcSEcCtD
Bromocriptine—Headache—Vincristine—kidney cancer	0.000142	0.000554	CcSEcCtD
Bromocriptine—Anorexia—Capecitabine—kidney cancer	0.000141	0.000549	CcSEcCtD
Bromocriptine—Sinusitis—Doxorubicin—kidney cancer	0.00014	0.000546	CcSEcCtD
Bromocriptine—Hypotension—Capecitabine—kidney cancer	0.000138	0.000539	CcSEcCtD
Bromocriptine—Vomiting—Gemcitabine—kidney cancer	0.000136	0.000533	CcSEcCtD
Bromocriptine—Bradycardia—Doxorubicin—kidney cancer	0.000136	0.000532	CcSEcCtD
Bromocriptine—ABCB1—nephron tubule—kidney cancer	0.000135	0.014	CbGeAlD
Bromocriptine—Rash—Gemcitabine—kidney cancer	0.000135	0.000529	CcSEcCtD
Bromocriptine—Dermatitis—Gemcitabine—kidney cancer	0.000135	0.000528	CcSEcCtD
Bromocriptine—Headache—Gemcitabine—kidney cancer	0.000134	0.000525	CcSEcCtD
Bromocriptine—Nausea—Vincristine—kidney cancer	0.000134	0.000525	CcSEcCtD
Bromocriptine—Rhinitis—Doxorubicin—kidney cancer	0.000134	0.000524	CcSEcCtD
Bromocriptine—Insomnia—Capecitabine—kidney cancer	0.000133	0.000521	CcSEcCtD
Bromocriptine—Hypoaesthesia—Doxorubicin—kidney cancer	0.000133	0.00052	CcSEcCtD
Bromocriptine—Paraesthesia—Capecitabine—kidney cancer	0.000132	0.000517	CcSEcCtD
Bromocriptine—Oedema peripheral—Doxorubicin—kidney cancer	0.000132	0.000515	CcSEcCtD
Bromocriptine—Connective tissue disorder—Doxorubicin—kidney cancer	0.000131	0.000514	CcSEcCtD
Bromocriptine—Dyspnoea—Capecitabine—kidney cancer	0.000131	0.000514	CcSEcCtD
Bromocriptine—Dyspepsia—Capecitabine—kidney cancer	0.00013	0.000507	CcSEcCtD
Bromocriptine—Visual impairment—Doxorubicin—kidney cancer	0.000129	0.000504	CcSEcCtD
Bromocriptine—Asthenia—Paclitaxel—kidney cancer	0.000129	0.000504	CcSEcCtD
Bromocriptine—Decreased appetite—Capecitabine—kidney cancer	0.000128	0.000501	CcSEcCtD
Bromocriptine—Nausea—Gemcitabine—kidney cancer	0.000127	0.000498	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000127	0.000498	CcSEcCtD
Bromocriptine—Fatigue—Capecitabine—kidney cancer	0.000127	0.000497	CcSEcCtD
Bromocriptine—Constipation—Capecitabine—kidney cancer	0.000126	0.000493	CcSEcCtD
Bromocriptine—Eye disorder—Doxorubicin—kidney cancer	0.000125	0.000489	CcSEcCtD
Bromocriptine—Tinnitus—Doxorubicin—kidney cancer	0.000125	0.000488	CcSEcCtD
Bromocriptine—Cardiac disorder—Doxorubicin—kidney cancer	0.000124	0.000485	CcSEcCtD
Bromocriptine—ABCB1—renal system—kidney cancer	0.000123	0.0127	CbGeAlD
Bromocriptine—Diarrhoea—Paclitaxel—kidney cancer	0.000123	0.00048	CcSEcCtD
Bromocriptine—Feeling abnormal—Capecitabine—kidney cancer	0.000121	0.000475	CcSEcCtD
Bromocriptine—Angiopathy—Doxorubicin—kidney cancer	0.000121	0.000474	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Capecitabine—kidney cancer	0.000121	0.000471	CcSEcCtD
Bromocriptine—Mediastinal disorder—Doxorubicin—kidney cancer	0.000121	0.000471	CcSEcCtD
Bromocriptine—Arrhythmia—Doxorubicin—kidney cancer	0.000119	0.000467	CcSEcCtD
Bromocriptine—ABCB1—kidney—kidney cancer	0.000119	0.0123	CbGeAlD
Bromocriptine—Dizziness—Paclitaxel—kidney cancer	0.000119	0.000464	CcSEcCtD
Bromocriptine—Alopecia—Doxorubicin—kidney cancer	0.000118	0.000462	CcSEcCtD
Bromocriptine—Mental disorder—Doxorubicin—kidney cancer	0.000117	0.000458	CcSEcCtD
Bromocriptine—Urticaria—Capecitabine—kidney cancer	0.000117	0.000458	CcSEcCtD
Bromocriptine—Body temperature increased—Capecitabine—kidney cancer	0.000117	0.000456	CcSEcCtD
Bromocriptine—Abdominal pain—Capecitabine—kidney cancer	0.000117	0.000456	CcSEcCtD
Bromocriptine—ABCB1—cortex of kidney—kidney cancer	0.000116	0.012	CbGeAlD
Bromocriptine—Tension—Doxorubicin—kidney cancer	0.000114	0.000447	CcSEcCtD
Bromocriptine—Vomiting—Paclitaxel—kidney cancer	0.000114	0.000447	CcSEcCtD
Bromocriptine—Dysgeusia—Doxorubicin—kidney cancer	0.000114	0.000446	CcSEcCtD
Bromocriptine—Rash—Paclitaxel—kidney cancer	0.000113	0.000443	CcSEcCtD
Bromocriptine—Dermatitis—Paclitaxel—kidney cancer	0.000113	0.000442	CcSEcCtD
Bromocriptine—Nervousness—Doxorubicin—kidney cancer	0.000113	0.000442	CcSEcCtD
Bromocriptine—Headache—Paclitaxel—kidney cancer	0.000113	0.00044	CcSEcCtD
Bromocriptine—Muscle spasms—Doxorubicin—kidney cancer	0.000112	0.000438	CcSEcCtD
Bromocriptine—ABCB1—gonad—kidney cancer	0.00011	0.0114	CbGeAlD
Bromocriptine—Vision blurred—Doxorubicin—kidney cancer	0.00011	0.000429	CcSEcCtD
Bromocriptine—Agitation—Doxorubicin—kidney cancer	0.000107	0.000418	CcSEcCtD
Bromocriptine—Nausea—Paclitaxel—kidney cancer	0.000107	0.000417	CcSEcCtD
Bromocriptine—Asthenia—Capecitabine—kidney cancer	0.000106	0.000413	CcSEcCtD
Bromocriptine—Vertigo—Doxorubicin—kidney cancer	0.000105	0.000409	CcSEcCtD
Bromocriptine—Syncope—Doxorubicin—kidney cancer	0.000104	0.000408	CcSEcCtD
Bromocriptine—Loss of consciousness—Doxorubicin—kidney cancer	0.000102	0.0004	CcSEcCtD
Bromocriptine—Convulsion—Doxorubicin—kidney cancer	0.000101	0.000394	CcSEcCtD
Bromocriptine—Diarrhoea—Capecitabine—kidney cancer	0.000101	0.000394	CcSEcCtD
Bromocriptine—Hypertension—Doxorubicin—kidney cancer	0.000101	0.000393	CcSEcCtD
Bromocriptine—Anxiety—Doxorubicin—kidney cancer	9.88e-05	0.000386	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	9.84e-05	0.000385	CcSEcCtD
Bromocriptine—Dizziness—Capecitabine—kidney cancer	9.75e-05	0.000381	CcSEcCtD
Bromocriptine—Dry mouth—Doxorubicin—kidney cancer	9.69e-05	0.000379	CcSEcCtD
Bromocriptine—Confusional state—Doxorubicin—kidney cancer	9.58e-05	0.000375	CcSEcCtD
Bromocriptine—Oedema—Doxorubicin—kidney cancer	9.5e-05	0.000371	CcSEcCtD
Bromocriptine—Infection—Doxorubicin—kidney cancer	9.44e-05	0.000369	CcSEcCtD
Bromocriptine—Vomiting—Capecitabine—kidney cancer	9.37e-05	0.000366	CcSEcCtD
Bromocriptine—Shock—Doxorubicin—kidney cancer	9.35e-05	0.000365	CcSEcCtD
Bromocriptine—Nervous system disorder—Doxorubicin—kidney cancer	9.32e-05	0.000364	CcSEcCtD
Bromocriptine—Rash—Capecitabine—kidney cancer	9.29e-05	0.000363	CcSEcCtD
Bromocriptine—Dermatitis—Capecitabine—kidney cancer	9.29e-05	0.000363	CcSEcCtD
Bromocriptine—Tachycardia—Doxorubicin—kidney cancer	9.27e-05	0.000363	CcSEcCtD
Bromocriptine—Headache—Capecitabine—kidney cancer	9.23e-05	0.000361	CcSEcCtD
Bromocriptine—Skin disorder—Doxorubicin—kidney cancer	9.23e-05	0.000361	CcSEcCtD
Bromocriptine—Anorexia—Doxorubicin—kidney cancer	9.06e-05	0.000354	CcSEcCtD
Bromocriptine—Hypotension—Doxorubicin—kidney cancer	8.88e-05	0.000347	CcSEcCtD
Bromocriptine—Nausea—Capecitabine—kidney cancer	8.76e-05	0.000342	CcSEcCtD
Bromocriptine—Insomnia—Doxorubicin—kidney cancer	8.59e-05	0.000336	CcSEcCtD
Bromocriptine—Paraesthesia—Doxorubicin—kidney cancer	8.53e-05	0.000334	CcSEcCtD
Bromocriptine—Dyspnoea—Doxorubicin—kidney cancer	8.47e-05	0.000331	CcSEcCtD
Bromocriptine—Somnolence—Doxorubicin—kidney cancer	8.45e-05	0.00033	CcSEcCtD
Bromocriptine—Dyspepsia—Doxorubicin—kidney cancer	8.36e-05	0.000327	CcSEcCtD
Bromocriptine—Decreased appetite—Doxorubicin—kidney cancer	8.26e-05	0.000323	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Doxorubicin—kidney cancer	8.2e-05	0.000321	CcSEcCtD
Bromocriptine—Fatigue—Doxorubicin—kidney cancer	8.19e-05	0.00032	CcSEcCtD
Bromocriptine—Constipation—Doxorubicin—kidney cancer	8.13e-05	0.000318	CcSEcCtD
Bromocriptine—Feeling abnormal—Doxorubicin—kidney cancer	7.83e-05	0.000306	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Doxorubicin—kidney cancer	7.77e-05	0.000304	CcSEcCtD
Bromocriptine—Urticaria—Doxorubicin—kidney cancer	7.55e-05	0.000295	CcSEcCtD
Bromocriptine—Body temperature increased—Doxorubicin—kidney cancer	7.51e-05	0.000294	CcSEcCtD
Bromocriptine—Abdominal pain—Doxorubicin—kidney cancer	7.51e-05	0.000294	CcSEcCtD
Bromocriptine—Asthenia—Doxorubicin—kidney cancer	6.82e-05	0.000267	CcSEcCtD
Bromocriptine—Diarrhoea—Doxorubicin—kidney cancer	6.5e-05	0.000254	CcSEcCtD
Bromocriptine—Dizziness—Doxorubicin—kidney cancer	6.28e-05	0.000246	CcSEcCtD
Bromocriptine—Vomiting—Doxorubicin—kidney cancer	6.04e-05	0.000236	CcSEcCtD
Bromocriptine—Rash—Doxorubicin—kidney cancer	5.99e-05	0.000234	CcSEcCtD
Bromocriptine—Dermatitis—Doxorubicin—kidney cancer	5.99e-05	0.000234	CcSEcCtD
Bromocriptine—Headache—Doxorubicin—kidney cancer	5.95e-05	0.000233	CcSEcCtD
Bromocriptine—Nausea—Doxorubicin—kidney cancer	5.64e-05	0.000221	CcSEcCtD
Bromocriptine—DRD2—Signaling by GPCR—KRAS—kidney cancer	4.65e-06	8.1e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling by GPCR—PIK3CA—kidney cancer	4.64e-06	8.07e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—MAPK3—kidney cancer	4.64e-06	8.07e-05	CbGpPWpGaD
Bromocriptine—HTR2A—GPCR downstream signaling—PIK3CA—kidney cancer	4.63e-06	8.07e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—CDKN1B—kidney cancer	4.63e-06	8.06e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—ERBB2—kidney cancer	4.63e-06	8.06e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—POMC—kidney cancer	4.61e-06	8.02e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—RAF1—kidney cancer	4.6e-06	8.01e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—CDKN1B—kidney cancer	4.59e-06	7.99e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—RELA—kidney cancer	4.58e-06	7.98e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—KRAS—kidney cancer	4.58e-06	7.97e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—MYC—kidney cancer	4.58e-06	7.97e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—MAPK3—kidney cancer	4.57e-06	7.96e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—MYC—kidney cancer	4.57e-06	7.96e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—MTOR—kidney cancer	4.57e-06	7.95e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—ERBB2—kidney cancer	4.55e-06	7.93e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—BRAF—kidney cancer	4.55e-06	7.92e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—MYC—kidney cancer	4.54e-06	7.91e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—BCHE—kidney cancer	4.54e-06	7.91e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—VEGFA—kidney cancer	4.54e-06	7.91e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—GPCR downstream signaling—PIK3CA—kidney cancer	4.54e-06	7.9e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—IL2—kidney cancer	4.53e-06	7.89e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—MAPK3—kidney cancer	4.5e-06	7.84e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—MTOR—kidney cancer	4.49e-06	7.82e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—IL2—kidney cancer	4.49e-06	7.82e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—SLC5A5—kidney cancer	4.49e-06	7.81e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—KRAS—kidney cancer	4.48e-06	7.81e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—MAPK1—kidney cancer	4.48e-06	7.8e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—MAPK1—kidney cancer	4.47e-06	7.79e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—MYC—kidney cancer	4.45e-06	7.75e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—MAPK1—kidney cancer	4.44e-06	7.74e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—ABCB1—kidney cancer	4.43e-06	7.72e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—CDKN1B—kidney cancer	4.43e-06	7.71e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—CCND1—kidney cancer	4.42e-06	7.69e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—MAPK1—kidney cancer	4.41e-06	7.68e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—JUN—kidney cancer	4.41e-06	7.67e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—CDKN1B—kidney cancer	4.41e-06	7.67e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—PTGS2—kidney cancer	4.39e-06	7.65e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—MYC—kidney cancer	4.38e-06	7.62e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—CCND1—kidney cancer	4.38e-06	7.62e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—CTNNB1—kidney cancer	4.37e-06	7.62e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—JUN—kidney cancer	4.37e-06	7.6e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—MAPK1—kidney cancer	4.35e-06	7.58e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—CTNNB1—kidney cancer	4.33e-06	7.55e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—IL2—kidney cancer	4.33e-06	7.55e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—SLC2A1—kidney cancer	4.33e-06	7.55e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—IL2—kidney cancer	4.31e-06	7.51e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—GSTM1—kidney cancer	4.3e-06	7.49e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—MAPK3—kidney cancer	4.3e-06	7.48e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—CDKN1B—kidney cancer	4.28e-06	7.46e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—VEGFA—kidney cancer	4.28e-06	7.46e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—MAPK1—kidney cancer	4.28e-06	7.46e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—PIK3CA—kidney cancer	4.28e-06	7.44e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—PTEN—kidney cancer	4.26e-06	7.42e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—RAF1—kidney cancer	4.24e-06	7.39e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—KRAS—kidney cancer	4.23e-06	7.37e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—VEGFA—kidney cancer	4.23e-06	7.36e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—VEGFA—kidney cancer	4.23e-06	7.36e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—KRAS—kidney cancer	4.22e-06	7.36e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—RELA—kidney cancer	4.22e-06	7.36e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—CCND1—kidney cancer	4.22e-06	7.36e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—PTEN—kidney cancer	4.22e-06	7.36e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—CDKN1B—kidney cancer	4.22e-06	7.34e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—JUN—kidney cancer	4.22e-06	7.34e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCR downstream signaling—PIK3CA—kidney cancer	4.21e-06	7.34e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—PIK3CA—kidney cancer	4.21e-06	7.33e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—CCND1—kidney cancer	4.2e-06	7.32e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—ERBB2—kidney cancer	4.2e-06	7.31e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—KRAS—kidney cancer	4.2e-06	7.31e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—JUN—kidney cancer	4.19e-06	7.3e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—IL2—kidney cancer	4.19e-06	7.3e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—CTNNB1—kidney cancer	4.18e-06	7.28e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—MYC—kidney cancer	4.18e-06	7.28e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—RAF1—kidney cancer	4.18e-06	7.27e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—KRAS—kidney cancer	4.17e-06	7.25e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—CTNNB1—kidney cancer	4.16e-06	7.25e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—RELA—kidney cancer	4.16e-06	7.24e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—MTOR—kidney cancer	4.14e-06	7.21e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—ERBB2—kidney cancer	4.13e-06	7.19e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—IL2—kidney cancer	4.13e-06	7.19e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—PIK3CA—kidney cancer	4.12e-06	7.17e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—KRAS—kidney cancer	4.11e-06	7.16e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—RAF1—kidney cancer	4.09e-06	7.12e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—CCND1—kidney cancer	4.09e-06	7.12e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—MAPK1—kidney cancer	4.09e-06	7.12e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—CYP1A1—kidney cancer	4.08e-06	7.1e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—JUN—kidney cancer	4.08e-06	7.1e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—PTEN—kidney cancer	4.08e-06	7.1e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—MTOR—kidney cancer	4.08e-06	7.1e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—RELA—kidney cancer	4.07e-06	7.09e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—PTEN—kidney cancer	4.06e-06	7.06e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—MAPK3—kidney cancer	4.05e-06	7.05e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—CTNNB1—kidney cancer	4.05e-06	7.05e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—ERBB2—kidney cancer	4.04e-06	7.04e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—KRAS—kidney cancer	4.04e-06	7.04e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—CCND1—kidney cancer	4.02e-06	7.01e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—JUN—kidney cancer	4.01e-06	6.99e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—MAPK3—kidney cancer	4e-06	6.96e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—MAPK3—kidney cancer	4e-06	6.96e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—MTOR—kidney cancer	3.99e-06	6.95e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—CTNNB1—kidney cancer	3.98e-06	6.94e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—PTEN—kidney cancer	3.95e-06	6.87e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—MYC—kidney cancer	3.94e-06	6.86e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—MYC—kidney cancer	3.89e-06	6.77e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—MYC—kidney cancer	3.89e-06	6.77e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—CDKN1B—kidney cancer	3.89e-06	6.77e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—PIK3CA—kidney cancer	3.89e-06	6.77e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—PTEN—kidney cancer	3.88e-06	6.76e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—PIK3CA—kidney cancer	3.88e-06	6.76e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—KRAS—kidney cancer	3.86e-06	6.72e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—PIK3CA—kidney cancer	3.86e-06	6.72e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—MAPK1—kidney cancer	3.85e-06	6.71e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—VEGFA—kidney cancer	3.85e-06	6.7e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—PTEN—kidney cancer	3.83e-06	6.67e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—PIK3CA—kidney cancer	3.83e-06	6.66e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CDKN1B—kidney cancer	3.83e-06	6.66e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—VEGFA—kidney cancer	3.81e-06	6.64e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—POMC—kidney cancer	3.81e-06	6.63e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—IL2—kidney cancer	3.8e-06	6.63e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—MAPK1—kidney cancer	3.8e-06	6.62e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—MAPK1—kidney cancer	3.8e-06	6.62e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—RAF1—kidney cancer	3.8e-06	6.61e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—RELA—kidney cancer	3.78e-06	6.59e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—PIK3CA—kidney cancer	3.78e-06	6.58e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—TP53—kidney cancer	3.76e-06	6.55e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—ERBB2—kidney cancer	3.76e-06	6.54e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—TP53—kidney cancer	3.75e-06	6.54e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CDKN1B—kidney cancer	3.75e-06	6.52e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—IL2—kidney cancer	3.74e-06	6.52e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—TP53—kidney cancer	3.73e-06	6.5e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—PIK3CA—kidney cancer	3.72e-06	6.47e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—CCND1—kidney cancer	3.71e-06	6.46e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—MTOR—kidney cancer	3.71e-06	6.46e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—JUN—kidney cancer	3.7e-06	6.45e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—VEGFA—kidney cancer	3.68e-06	6.41e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—CTNNB1—kidney cancer	3.67e-06	6.4e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—IL2—kidney cancer	3.67e-06	6.38e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—VEGFA—kidney cancer	3.66e-06	6.38e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—TP53—kidney cancer	3.65e-06	6.36e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CCND1—kidney cancer	3.65e-06	6.35e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—MAPK3—kidney cancer	3.64e-06	6.34e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—JUN—kidney cancer	3.64e-06	6.34e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—KRAS—kidney cancer	3.64e-06	6.34e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CTNNB1—kidney cancer	3.61e-06	6.29e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—GSTP1—kidney cancer	3.61e-06	6.29e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—MAPK3—kidney cancer	3.61e-06	6.28e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—TP53—kidney cancer	3.59e-06	6.26e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—KRAS—kidney cancer	3.59e-06	6.26e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—KRAS—kidney cancer	3.59e-06	6.26e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—PTEN—kidney cancer	3.58e-06	6.23e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CCND1—kidney cancer	3.57e-06	6.22e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—JUN—kidney cancer	3.57e-06	6.21e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—VEGFA—kidney cancer	3.56e-06	6.21e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—PIK3CA—kidney cancer	3.55e-06	6.18e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—MYC—kidney cancer	3.54e-06	6.17e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CTNNB1—kidney cancer	3.54e-06	6.16e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—PTEN—kidney cancer	3.52e-06	6.13e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—MYC—kidney cancer	3.51e-06	6.11e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—VEGFA—kidney cancer	3.51e-06	6.11e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—MAPK3—kidney cancer	3.48e-06	6.07e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CDKN1B—kidney cancer	3.48e-06	6.06e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—MAPK3—kidney cancer	3.47e-06	6.04e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—MAPK1—kidney cancer	3.47e-06	6.03e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—PTEN—kidney cancer	3.45e-06	6.01e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—MAPK1—kidney cancer	3.43e-06	5.98e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—TP53—kidney cancer	3.43e-06	5.98e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—ABCB1—kidney cancer	3.42e-06	5.96e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—IL2—kidney cancer	3.41e-06	5.93e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—MYC—kidney cancer	3.39e-06	5.9e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—MAPK3—kidney cancer	3.37e-06	5.87e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—MYC—kidney cancer	3.37e-06	5.87e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.35e-06	5.84e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—PIK3CA—kidney cancer	3.34e-06	5.82e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Metabolism—PIK3CA—kidney cancer	3.33e-06	5.8e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—GSTM1—kidney cancer	3.32e-06	5.78e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CCND1—kidney cancer	3.32e-06	5.78e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—MAPK3—kidney cancer	3.32e-06	5.78e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—MAPK1—kidney cancer	3.31e-06	5.77e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—JUN—kidney cancer	3.31e-06	5.77e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—PIK3CA—kidney cancer	3.3e-06	5.75e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—PIK3CA—kidney cancer	3.3e-06	5.75e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—MAPK1—kidney cancer	3.3e-06	5.74e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CTNNB1—kidney cancer	3.29e-06	5.73e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—MYC—kidney cancer	3.28e-06	5.71e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—KRAS—kidney cancer	3.27e-06	5.7e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—KRAS—kidney cancer	3.24e-06	5.65e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—TP53—kidney cancer	3.24e-06	5.63e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—VEGFA—kidney cancer	3.23e-06	5.63e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—MYC—kidney cancer	3.23e-06	5.62e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—MAPK1—kidney cancer	3.21e-06	5.59e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—PTEN—kidney cancer	3.2e-06	5.58e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—TP53—kidney cancer	3.19e-06	5.56e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—TP53—kidney cancer	3.19e-06	5.56e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—VEGFA—kidney cancer	3.18e-06	5.54e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—MAPK1—kidney cancer	3.16e-06	5.5e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—CYP1A1—kidney cancer	3.15e-06	5.48e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—KRAS—kidney cancer	3.13e-06	5.45e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—VEGFA—kidney cancer	3.12e-06	5.42e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—KRAS—kidney cancer	3.11e-06	5.42e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—MAPK3—kidney cancer	3.06e-06	5.33e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—POMC—kidney cancer	3.04e-06	5.3e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—PTGS2—kidney cancer	3.04e-06	5.29e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—KRAS—kidney cancer	3.03e-06	5.28e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—MAPK3—kidney cancer	3.01e-06	5.24e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—PIK3CA—kidney cancer	3.01e-06	5.24e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—KRAS—kidney cancer	2.98e-06	5.19e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—PIK3CA—kidney cancer	2.98e-06	5.19e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—MYC—kidney cancer	2.97e-06	5.18e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—MAPK3—kidney cancer	2.95e-06	5.13e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—MYC—kidney cancer	2.93e-06	5.1e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—MAPK1—kidney cancer	2.91e-06	5.07e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—TP53—kidney cancer	2.91e-06	5.07e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—VEGFA—kidney cancer	2.89e-06	5.04e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—TP53—kidney cancer	2.88e-06	5.02e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—PIK3CA—kidney cancer	2.88e-06	5.01e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—MYC—kidney cancer	2.87e-06	4.99e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—MAPK1—kidney cancer	2.86e-06	4.99e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—PIK3CA—kidney cancer	2.86e-06	4.98e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—MAPK1—kidney cancer	2.8e-06	4.88e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—PIK3CA—kidney cancer	2.78e-06	4.85e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—TP53—kidney cancer	2.78e-06	4.85e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—TP53—kidney cancer	2.77e-06	4.82e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—KRAS—kidney cancer	2.75e-06	4.79e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—PIK3CA—kidney cancer	2.74e-06	4.77e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—MAPK3—kidney cancer	2.74e-06	4.77e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—KRAS—kidney cancer	2.7e-06	4.71e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—PIK3CA—kidney cancer	2.7e-06	4.71e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—TP53—kidney cancer	2.69e-06	4.69e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—MYC—kidney cancer	2.66e-06	4.64e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—PTEN—kidney cancer	2.65e-06	4.61e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—TP53—kidney cancer	2.65e-06	4.61e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—KRAS—kidney cancer	2.65e-06	4.61e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—MAPK1—kidney cancer	2.61e-06	4.54e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—PIK3CA—kidney cancer	2.53e-06	4.4e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—PIK3CA—kidney cancer	2.48e-06	4.33e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—KRAS—kidney cancer	2.46e-06	4.29e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—TP53—kidney cancer	2.44e-06	4.25e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—PIK3CA—kidney cancer	2.43e-06	4.24e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PTGS2—kidney cancer	2.43e-06	4.22e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—TP53—kidney cancer	2.4e-06	4.19e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—TP53—kidney cancer	2.35e-06	4.1e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—POMC—kidney cancer	2.35e-06	4.09e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—PIK3CA—kidney cancer	2.26e-06	3.94e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—TP53—kidney cancer	2.19e-06	3.81e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PTEN—kidney cancer	2.12e-06	3.68e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PTGS2—kidney cancer	1.87e-06	3.26e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—PIK3CA—kidney cancer	1.87e-06	3.26e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PTEN—kidney cancer	1.63e-06	2.84e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PIK3CA—kidney cancer	1.49e-06	2.6e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.15e-06	2.01e-05	CbGpPWpGaD
